cysteamine has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SW; Cho, YS; Choi, SY; Eom, SA; Eum, WS; Hwang, HS; Kim, DS; Kim, DW; Kim, YN; Lee, SH; Park, J; Sohn, EJ; Yoon, GH | 1 |
| Hasegawa, E; Murai, Y; Oishi, T | 1 |
2 other study(ies) available for cysteamine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line; Cysteamine; Disease Models, Animal; DNA Fragmentation; Dopaminergic Neurons; Genetic Vectors; Humans; Mice; MPTP Poisoning; Oxidative Stress; Parkinson Disease; Peptides | 2012 |
Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Cysteamine; Dimercaprol; Dopamine; Dopamine Agents; Glutathione; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Nervous System Diseases; Pyridinium Compounds; Sulfhydryl Compounds | 1993 |